Celldex to Report Fourth Quarter and Fiscal 2014 Business/Financial Results and Host 2015 Corporate Strategy Conference Call
February 19 2015 - 4:01PM
--Conference Call Scheduled
for Tuesday, February 24 at 8:00 a.m. Eastern Time--
Celldex Therapeutics, Inc. (Nasdaq:CLDX) will release fourth
quarter and year-end 2014 financial results on Tuesday, February
24, 2015 before the U.S. financial markets open. Celldex executives
will host a conference call at 8:00 a.m. ET on the same day to
discuss 2014 financial and business results and to provide an
update on key 2015 objectives.
The conference call and presentation will be webcast live over
the Internet and can be accessed by going to the "Events &
Presentations" page under the "Investors & Media" section of
the Celldex Therapeutics website at www.celldex.com. The
call can also be accessed by dialing (866) 743-9666
(within the United States) or (760) 298-5103 (outside the
United States). The passcode is 89115872.
A replay of the call will be available approximately two hours
after the live call concludes through March 2, 2015. To access
the replay, dial (855) 859-2056 (within the United States) or
(404) 537-3406 (outside the United States). The passcode is
89115872. The webcast will also be archived on the Company's
website.
About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address
devastating diseases for which available treatments are inadequate.
Our pipeline is built from a proprietary portfolio of antibodies
and immunomodulators used alone and in strategic combinations to
create novel, disease-specific therapies that induce, enhance or
suppress the body's immune response. Visit www.celldex.com.
CONTACT: Company Contact:
Sarah Cavanaugh
Vice President of Investor Relations &
Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3161
scavanaugh@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Apr 2023 to Apr 2024